{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:50:04Z","timestamp":1792007404404,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015616","name":"Gray Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA233259"],"award-info":[{"award-number":["CA233259"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA271896"],"award-info":[{"award-number":["CA271896"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA121113"],"award-info":[{"award-number":["CA121113"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"Stand up to Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT1415"],"award-info":[{"award-number":["SU2C-AACR-DT1415"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000905","name":"Commonwealth Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004436","name":"Commonwealth Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006535","name":"Entertainment Industry Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["10438"],"award-info":[{"award-number":["10438"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","award":["LSHM22027"],"award-info":[{"award-number":["LSHM22027"]}],"id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010441","name":"Medizinischen Fakult\u00e4t Heidelberg, Universit\u00e4t Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019683","name":"Cole Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019683","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["513004649"],"award-info":[{"award-number":["513004649"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106081","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T03:50:24Z","timestamp":1765857024000},"page":"106081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases"],"prefix":"10.1016","volume":"123","author":[{"given":"Nerma","family":"Crnovrsanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michiel","family":"Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsoem","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Kemna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Alipanahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lumbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary L.","family":"Skidmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"van 't Erve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina J.","family":"Wesdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Huiskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"van Steijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hein","family":"van Waesberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Nota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinde J.G.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Meiqari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Huitink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giovannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9822-3784","authenticated-orcid":false,"given":"Jaap","family":"Stoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez","family":"Verpalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit A.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger-Jan","family":"Swijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.A.","family":"Punt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Scharpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Dracopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Velculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels F.M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-5521","authenticated-orcid":false,"given":"Remond J.A.","family":"Fijneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2025.106081_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106081_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1470-2045(23)00271-1","article-title":"Initially unresectable colorectal liver metastases: the best therapeutic regimens","volume":"24","author":"Imai","year":"2023","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/SLA.0000000000004331","article-title":"Choices of therapeutic strategies for colorectal liver metastases among expert liver surgeons: a throw of the dice?","volume":"272","author":"Ignatavicius","year":"2020","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106081_bib4","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1245\/s10434-023-13510-7","article-title":"Intersurgeon variability in local treatment planning for patients with initially unresectable colorectal cancer liver metastases: analysis of the liver expert panel of the Dutch Colorectal Cancer Group","volume":"30","author":"Bond","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ebiom.2025.106081_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejca.2023.01.013","article-title":"The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: an analysis of the Dutch CAIRO5 trial","volume":"183","author":"Bolhuis","year":"2023","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102991","article-title":"Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience","volume":"9","author":"Moretto","year":"2024","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.gastro.2016.02.060","article-title":"Deciphering the molecular code to colorectal liver metastasis biology through microsatellite alterations and allelic loss: the good, the bad, and the ugly","volume":"150","author":"S\u00f8reide","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106081_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/hpb.12316","article-title":"Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens","volume":"17","author":"Truant","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"19","key":"10.1016\/j.ebiom.2025.106081_bib9","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1158\/1078-0432.CCR-19-0863","article-title":"Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases","volume":"25","author":"Kawaguchi","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1053\/j.gastro.2015.12.032","article-title":"Microsatellite alterations with allelic loss at 9p24.2 signify less-Aggressive Colorectal Cancer Metcstasis","volume":"150","author":"Koi","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106081_bib11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bjs.10838","article-title":"Genetic and Morphological Evaluation (GAME) score for patients with colorectal liver metastases","volume":"105","author":"Margonis","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ebiom.2025.106081_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114185","article-title":"Prognostic value of total tumor volume in patients with colorectal liver metastases: a secondary analysis of the randomized CAIRO5 trial with external cohort validation","volume":"207","author":"Michiel Zeeuw","year":"2024","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106081_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.annonc.2023.12.007","article-title":"Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)","volume":"35","author":"Gouda","year":"2024","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106081_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"10.1016\/j.ebiom.2025.106081_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006013","article-title":"Cell-free DNA approaches for cancer early detection and interception","volume":"11","author":"Medina","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1158\/1078-0432.CCR-22-2538","article-title":"Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells","volume":"29","author":"van 't Erve","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"7761","key":"10.1016\/j.ebiom.2025.106081_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib18","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1038\/s41467-024-53017-7","article-title":"Cancer treatment monitoring using cell-free DNA fragmentomes","volume":"15","author":"van \u2019t Erve","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib19","article-title":"Circulating DNA fragmentomics and cancer screening","volume":"3","author":"Thierry","year":"2023","journal-title":"Cell Genom"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106081_bib20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-021-01635-z","article-title":"At the dawn: cell-free DNA fragmentomics and gene regulation","volume":"126","author":"Liu","year":"2022","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","article-title":"Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection","volume":"25","author":"Bruhm","year":"2025","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106081_bib22","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/clinchem\/hvaa258","article-title":"Cell-Free DNA Fragmentomics: The New \u201cOmics\u201d on the Block","volume":"66","author":"Chiu","year":"2020","journal-title":"Clin Chem"},{"issue":"14","key":"10.1016\/j.ebiom.2025.106081_bib23","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/1878-0261.13267","article-title":"Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients","volume":"16","author":"Vessies","year":"2022","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib24","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","article-title":"Detection and characterization of lung cancer using cell-free DNA fragmentomes","volume":"12","author":"Mathios","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1158\/2159-8290.CD-24-0393","article-title":"Early detection of ovarian cancer using cell-free DNA Fragmentomes and Protein Biomarkers","volume":"15","author":"Medina","year":"2025","journal-title":"Cancer Discov"},{"issue":"16_suppl","key":"10.1016\/j.ebiom.2025.106081_bib26","doi-asserted-by":"crossref","first-page":"e14544","DOI":"10.1200\/JCO.2024.42.16_suppl.e14544","article-title":"Development of a novel cell-free DNA fragmentomics assay for monitoring disease progression in real-time for stage IV cancer patients","volume":"42","author":"Sinha","year":"2024","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ebiom.2025.106081_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads5002","article-title":"Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer","volume":"11","author":"Hruban","year":"2025","journal-title":"Sci Adv"},{"issue":"50","key":"10.1016\/j.ebiom.2025.106081_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc4308","article-title":"A mathematical model of ctDNA shedding predicts tumor detection size","volume":"6","author":"Avanzini","year":"2020","journal-title":"Sci Adv"},{"issue":"7655","key":"10.1016\/j.ebiom.2025.106081_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106081_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cjp2.207","article-title":"Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid","volume":"7","author":"Van't Erve","year":"2021","journal-title":"J Pathol Clin Res"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106081_bib31","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jmoldx.2024.07.001","article-title":"The correlation between plasma circulating tumor DNA and radiographic tumor burden","volume":"26","author":"Alexander","year":"2024","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.1016\/j.ebiom.2025.106081_bib32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41416-022-01816-4","article-title":"Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis","volume":"127","author":"Callesen","year":"2022","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106081_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(23)00219-X","article-title":"First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group","volume":"24","author":"Bond","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2025.106081_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2024.5174","article-title":"First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial","volume":"11","author":"Bond","year":"2025","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ebiom.2025.106081_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12885-015-1323-9","article-title":"Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)","volume":"15","author":"Huiskens","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib37","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000103","article-title":"The prognostic value of total tumor volume response compared with RECIST1.1 in patients with initially unresectable colorectal liver metastases undergoing systemic treatment","volume":"2","author":"Wesdorp","year":"2021","journal-title":"Ann Surg Open"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106081_bib39","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41416-023-02445-1","article-title":"Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors","volume":"129","author":"Thompson","year":"2023","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.ebiom.2025.106081_bib40","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/sim.9717","article-title":"Pitfalls of the concordance index for survival outcomes","volume":"42","author":"Hartman","year":"2023","journal-title":"Stat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106081_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00244","article-title":"Circulating tumor DNA as a marker of minimal residual disease after radical resection of colorectal liver metastases","volume":"6","author":"Marmorino","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106081_bib42","doi-asserted-by":"crossref","DOI":"10.1200\/CCI.23.00111","article-title":"Circulating tumor DNA in colorectal cancer liver metastasis: analysis of patients receiving liver resection and transplant","volume":"7","author":"Wehrle","year":"2023","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.ebiom.2025.106081_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103498","article-title":"Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases","volume":"70","author":"Bolhuis","year":"2021","journal-title":"eBioMedicine"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003620","article-title":"Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study","volume":"18","author":"Tie","year":"2021","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib45","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41416-022-01837-z","article-title":"Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment","volume":"127","author":"Kim","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2025.106081_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231171580","article-title":"Circulating tumor DNA: response evaluation criteria in solid tumors - can we RECIST? Focus on colorectal cancer","volume":"15","author":"Spindler","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ebiom.2025.106081_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101883","article-title":"Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment","volume":"42","author":"Egger","year":"2024","journal-title":"Transl Oncol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/bjc.2017.215","article-title":"Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients","volume":"117","author":"Winther-Larsen","year":"2017","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2025.106081_bib49","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.2967\/jnumed.117.193201","article-title":"Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer: (18)F-FDG PET\/CT study","volume":"58","author":"Morbelli","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.106081_bib50","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/ijc.32586","article-title":"Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma","volume":"146","author":"Strijker","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ebiom.2025.106081_bib51","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.annonc.2023.11.008","article-title":"Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer","volume":"35","author":"Tran","year":"2024","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.16.00009","article-title":"Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma","volume":"1","author":"Wong","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41523-021-00239-3","article-title":"Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk","volume":"7","author":"Magbanua","year":"2021","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib54","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.ebiom.2025.106081_bib55","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106081_bib56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models","volume":"176","author":"Pencina","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ebiom.2025.106081_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e686","article-title":"Assessing the value of diagnostic tests: a framework for designing and evaluating trials","volume":"344","author":"Ferrante di Ruffano","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106081_bib58","doi-asserted-by":"crossref","DOI":"10.1200\/PO.21.00535","article-title":"Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer","volume":"6","author":"Bando","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2025.106081_bib59","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/s41591-022-01886-0","article-title":"Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial","volume":"28","author":"Sartore-Bianchi","year":"2022","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.106081_bib60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827b","article-title":"Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients","volume":"21","author":"Siravegna","year":"2015","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.106081_bib61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/1078-0432.CCR-24-0924","article-title":"Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy","volume":"31","author":"Ghidini","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ebiom.2025.106081_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114186","article-title":"Exploring the biology of ctDNA release in colorectal cancer","volume":"207","author":"Andersen","year":"2024","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13244-024-01820-7","article-title":"Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA)","volume":"15","author":"Bereska","year":"2024","journal-title":"Insights Imaging"},{"key":"10.1016\/j.ebiom.2025.106081_bib64","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1200\/PO.20.00321","article-title":"Serial monitoring of circulating tumor DNA by next-generation gene sequencing as a biomarker of response and survival in patients with advanced NSCLC receiving pembrolizumab-based therapy","volume":"5","author":"Thompson","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"12","key":"10.1016\/j.ebiom.2025.106081_bib65","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/2159-8290.CD-20-0047","article-title":"Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.ebiom.2025.106081_bib66","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41591-023-02598-9","article-title":"ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results","volume":"29","author":"Anagnostou","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ebiom.2025.106081_bib67","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/0008-5472.CAN-18-1127","article-title":"Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer","volume":"79","author":"Anagnostou","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2025.106081_bib68","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425005316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:07:15Z","timestamp":1773900435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425005316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":68,"alternative-id":["S2352396425005316"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106081","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106081"}}